Business Description
Avanos Medical Inc
NAICS : 339113
SIC : 3842
ISIN : US05350V1061
Total Employee Number:
2,287Description
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -6.41 | |||||
Interest Coverage | 1.94 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.29 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.5 | |||||
3-Year EPS without NRI Growth Rate | -17.1 | |||||
3-Year FCF Growth Rate | -15 | |||||
3-Year Book Growth Rate | -15.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.19 | |||||
9-Day RSI | 49.1 | |||||
14-Day RSI | 53.14 | |||||
3-1 Month Momentum % | 81.36 | |||||
6-1 Month Momentum % | 117.26 | |||||
12-1 Month Momentum % | 114 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.5 | |||||
Days Inventory | 147.12 | |||||
Days Sales Outstanding | 54.29 | |||||
Days Payable | 52.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 4.35 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.05 | |||||
Operating Margin % | 1.96 | |||||
Net Margin % | -10.39 | |||||
EBITDA Margin % | -3.02 | |||||
FCF Margin % | 1 | |||||
OCF Margin % | 5.08 | |||||
ROE % | -9.41 | |||||
ROA % | -6.97 | |||||
ROIC % | 1.63 | |||||
3-Year ROIIC % | 2.01 | |||||
ROC (Joel Greenblatt) % | -21.33 | |||||
ROCE % | -6.61 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 24.53 | |||||
PE Ratio without NRI | 27.69 | |||||
PS Ratio | 1.62 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 4.25 | |||||
Price-to-Free-Cash-Flow | 145.73 | |||||
Price-to-Operating-Cash-Flow | 31.19 | |||||
EV-to-EBIT | -20.3 | |||||
EV-to-EBITDA | -57.42 | |||||
EV-to-Revenue | 1.73 | |||||
EV-to-FCF | 165.37 | |||||
Price-to-GF-Value | 1.28 | |||||
Price-to-Projected-FCF | 1.2 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
Price-to-Graham-Number | 2.29 | |||||
| Price-to-Net-Current-Asset-Value | 20.38 | |||||
Earnings Yield (Greenblatt) % | -4.93 | |||||
FCF Yield % | 0.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avanos Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 615.303 | ||
| EPS (TTM) (€) | -1.396 | ||
| Beta | 2.3334 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 75.92 | ||
| 14-Day RSI | 53.14 | ||
| 14-Day ATR (€) | 0.186433 | ||
| 20-Day SMA (€) | 21.44 | ||
| 12-1 Month Momentum % | 114 | ||
| 52-Week Range (€) | 8.5 - 21.8 | ||
| Shares Outstanding (Mil) | 46.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avanos Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avanos Medical Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 09:00 | In 120 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 119 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 09:00 | In 28 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 27 days | ||
| First quarter earnings conference call for 2026 | 2026-05-12 | 20.80 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-05 | 20.80 (+0.00%) | ||
| General meeting for 2026 | 2026-04-21 09:00 | 20.40 (+0.00%) | ||
| Guidance call for 2026 | 2026-03-11 13:05 | 11.10 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-24 09:00 | 12.80 (+0.00%) | ||
| Annual report for 2025 | 2026-02-24 | 12.80 (+0.00%) |
Show
Entries
Avanos Medical Inc Frequently Asked Questions
What is Avanos Medical Inc(FRA:8HH)'s stock price today?
The current price of FRA:8HH is €21.40. The 52 week high of FRA:8HH is €21.80 and 52 week low is €8.50.
When is next earnings date of Avanos Medical Inc(FRA:8HH)?
The next earnings date of Avanos Medical Inc(FRA:8HH) is 2026-08-05 Est..
Does Avanos Medical Inc(FRA:8HH) pay dividends? If so, how much?
Avanos Medical Inc(FRA:8HH) does not pay dividend.
Press Release
Articles on Avanos Medical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers